Royalty Pharma Plc • RPRX

Capital at risk.

Calendar
event
Ex dividend date
15 May 2026
event_available
Last Dividend Payment
10 Jun 2026
About Royalty Pharma Plc
Ticker
info
RPRX
Trading on
info
NASDAQ
ISIN
info
GB00BMVP7Y09
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Pablo Legorreta
Headquarters
info
110 East 59th Street, New York, NY, United States, 10022
Employees
info
100
Website
info
royaltypharma.com
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Metrics
BasicAdvanced
Market cap
info
$30.5B
P/E ratio
info
27.87
EPS
info
$1.90
Dividend Yield
info
1.67%
Beta
info
0.42
Forward P/E ratio
info
44.25
EBIDTA
info
$1.56B
Ex dividend date
info
2026-05-15
Price & volume
Market cap
info
$30.5B
Average daily volume
info
4.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.90
Dividend yield
info
1.67%
Forward dividend per share
info
$0.94
Forward dividend yield
info
1.77%
Payout ratio
info
17.91%
Valuation
P/E ratio
info
27.87
Forward P/E
info
44.25
PEG ratio
info
2
Trailing P/E
info
27.87
Price to sales
info
12.64
Price to book
info
3.45
Earnings
EPS
info
$1.90
EPS estimate (current quarter)
info
$1.18
EPS estimate (next quarter)
info
$1.28
EBITDA
info
$1.56B
Revenues (TTM)
info
$2.44B
Revenues per share (TTM)
info
$5.67
Technicals
Beta
info
0.42
52-week High
info
$56.50
52-week Low
info
$33.57
50-day moving average
info
$52.01
200-day moving average
info
$43.35
Short ratio
info
2.76
Short %
info
2.65%
Management effectiveness
ROE (TTM)
info
13.77%
ROA (TTM)
info
5.54%
Profit margin
info
33.86%
Gross profit margin
info
$2.81B
Operating margin
info
100.30%
Growth
Quarterly earnings growth (YoY)
info
23.20%
Quarterly revenue growth (YoY)
info
11.00%
Share stats
Outstanding Shares
info
443M
Float
info
413M
Insiders %
info
6.53%
Institutions %
info
88.07%
Analyst Insights & forecasts
info

75% Buy

25% Hold

0% Sell

Based on information from 8 analysts.

Average price target

info
$59.25
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.14
$1.03
10.68%
Q2 • 25Beat
$1.17
$1.11
5.41%
Q3 • 25Beat
$1.47
$1.33
10.53%
Q4 • 25Beat
$1.30
$1.18
10.17%
Q1 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$622M
$214M
34.44%
Q4 • 25
$631M
$295M
46.78%
Q1 • 26
1.38%
37.72%
35.84%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$19.6B
$9.91B
50.49%
Q4 • 25
$19.8B
$9.88B
49.85%
Q1 • 26
0.99%
-0.28%
-1.26%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$827M
$-850M
$-300M
$827M
Q4 • 25
$761M
$-470M
$-273M
$761M
Q1 • 26
-8.05%
-44.69%
-8.99%
-8.05%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Royalty Pharma Plc share?
Collapse

Royalty Pharma Plc shares are currently traded for undefined per share.

How many shares does Royalty Pharma Plc have?
Collapse

Royalty Pharma Plc currently has 443M shares.

Does Royalty Pharma Plc pay dividends?
Collapse

Yes, Royalty Pharma Plc does pay dividends.

What is Royalty Pharma Plc 52 week high?
Collapse

Royalty Pharma Plc 52 week high is $56.50.

What is Royalty Pharma Plc 52 week low?
Collapse

Royalty Pharma Plc 52 week low is $33.57.

What is the 200-day moving average of Royalty Pharma Plc?
Collapse

Royalty Pharma Plc 200-day moving average is $43.35.

Who is Royalty Pharma Plc CEO?
Collapse

The CEO of Royalty Pharma Plc is Pablo Legorreta.

How many employees Royalty Pharma Plc has?
Collapse

Royalty Pharma Plc has 100 employees.

What is the market cap of Royalty Pharma Plc?
Collapse

The market cap of Royalty Pharma Plc is $30.5B.

What is the P/E of Royalty Pharma Plc?
Collapse

The current P/E of Royalty Pharma Plc is 27.87.

What is the EPS of Royalty Pharma Plc?
Collapse

The EPS of Royalty Pharma Plc is $1.90.

What is the PEG Ratio of Royalty Pharma Plc?
Collapse

The PEG Ratio of Royalty Pharma Plc is 2.

What do analysts say about Royalty Pharma Plc?
Collapse

According to the analysts Royalty Pharma Plc is considered a buy.